Colonic Perforation After Treatment With Nivolumab in Esophageal Cancer: A Case Report

With the advent of checkpoint inhibitors, it has opened up opportunities for numerous cancer patients. However, as is the case with every treatment, complications need to be weighed. Gastrointestinal adverse effects, such as diarrhea and colitis are well-known complications for checkpoint inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Hye Jung, Kim, Woo Ram, Kim, Joo-Hang, Kim, Duk Hwan, Kim, Dae Jung, Kang, Haeyoun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Coloproctology 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359691/
https://www.ncbi.nlm.nih.gov/pubmed/34167190
http://dx.doi.org/10.3393/ac.2020.00213.0030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359691/
https://www.ncbi.nlm.nih.gov/pubmed/34167190
http://dx.doi.org/10.3393/ac.2020.00213.0030

Ejemplares similares